Welcome to CDC Stacks | Nosocomial bacteremias associated with intravenous fluid therapy - USA - 1741 | Morbidity and Mortality Weekly Report (MMWR)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All Simple Search
Advanced Search
Nosocomial bacteremias associated with intravenous fluid therapy - USA
  • Published Date:
    March 6, 1971
Filetype[PDF - 382.31 KB]

  • Corporate Authors:
    Center for Disease Control ; United States, Dept. of Health, Education, and Welfare, Public Health Service ; United States, Health Services and Mental Health Administration
  • Series:
    Morbidity and mortality weekly report ; v. 20, no. 9, Special supplement
  • Document Type:
  • Description:
    Between October 1970 and March 1, 1971, eight United States Hospitals in seven states experienced 150 bacteremias caused by Enterobacter cloacae or Gram-negative organisms of the Erwinia group. There were nine deaths; all were associated with intravenous (IV) fluid therapy. The Enterobacter bacteremias in all hospitals were substantially increased as compared to previous time periods. Four hospitals which isolated and identified Erwinia had not previously encountered infections with these organisms. In-depth epidemiologic investigations were performed in three of the hospitals (Figure 1).

    All eight hospitals utilize fluids and systems manufactured by Abbott Laboratories, which produces approximately 45 percent of all IV fluids sold within the United States. In approximately 30 cases, the same organisms were isolated from blood cultures and contaminated in Use IV fluids. In hospital B (see arrow, Figure 1) no further cases were observed after discontinuance of Abbott products.

  • Supporting Files:
    No Additional Files